Voice of America - October 31, 2006
Joe De Capua
Washington

Click to download/open (MP3)
Click to download/open (Real Audio)

In Paris, the worlds top health experts are meeting this week to decide what to do about extremely drug resistant tuberculosis - also known as XDR-TB. The 37th Union World Conference on Lung Health will also consider related issues, such as the shortage of health care workers and inadequate health care systems.

Dr. Nils Billo is director of the International Union Against Tuberculosis and Lung Disease. From Paris, he spoke to VOA English to Africa Service reporter Joe De Capua about the threat of XDR-TB.

"This is a threat, especially where you have a lot TB and a lot of HIV. And that is the case in South Africa where this new ultra resistant TB was detected a few months ago and with more or less a 100 percent fatality (rate). And Obviously the WHO (World Health Organization) and other international authorities are now are trying assess if this is happening in other countries, although at the moment it seems like it's only in a few isolated countries...(it's) probably only going to be happening in a situation where you have a deficient health care system, where you have a lot of TB and a lot of HIV occurring at the same time," he says.

Dr. Billo says that there's no reason to panic at this time, but he says the situation needs to be closely supervised.

Asked about the lack of treatments available for XDR-TB, he says, "There's only very little funding being given for the development of new drugs and new vaccines and diagnostics." He says those at the conference recommended that research funding for TB be increased from $400 million a year to $2 billion.

The 37th Union World Conference on Lung Health continues until November 4th.

061031
VA061015

Copyright © 2006 - Voice of America. You are welcome to use any material that is published by voanews.com, or you may link to any of the web pages that Voice of America has published on the internet. There is no need to request further permission. Should you wish to establish a link to any VOA web pages, please send your request to pubaff@ibb.gov. We would appreciate that credit for any use of VOA material be given to voanews.com, Voice of America, or VOA, and we ask that you not abridge or edit any VOA material which you may use.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, the National Library of Medicine, Bridgestone Firestone Trust Fund, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .